JPH10513177A5 - - Google Patents

Info

Publication number
JPH10513177A5
JPH10513177A5 JP1996523385A JP52338596A JPH10513177A5 JP H10513177 A5 JPH10513177 A5 JP H10513177A5 JP 1996523385 A JP1996523385 A JP 1996523385A JP 52338596 A JP52338596 A JP 52338596A JP H10513177 A5 JPH10513177 A5 JP H10513177A5
Authority
JP
Japan
Prior art keywords
melatonin
benzodiazepine
drug
patients
benzodiazepines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1996523385A
Other languages
English (en)
Japanese (ja)
Other versions
JPH10513177A (ja
JP4516159B2 (ja
Filing date
Publication date
Priority claimed from US08/381,535 external-priority patent/US6469044B1/en
Application filed filed Critical
Priority claimed from PCT/IB1996/000082 external-priority patent/WO1996023496A1/en
Publication of JPH10513177A publication Critical patent/JPH10513177A/ja
Publication of JPH10513177A5 publication Critical patent/JPH10513177A5/ja
Application granted granted Critical
Publication of JP4516159B2 publication Critical patent/JP4516159B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP52338596A 1995-02-01 1996-01-29 薬物嗜癖患者の治療のためのメラトニンの使用 Expired - Lifetime JP4516159B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/381,535 US6469044B1 (en) 1995-02-01 1995-02-01 Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies
GB381,535 1995-06-06
GB95303853.6 1995-06-06
EP95303853A EP0724878B1 (en) 1995-02-01 1995-06-06 Use of melatonin for treating patients suffering from drug dependencies
PCT/IB1996/000082 WO1996023496A1 (en) 1995-02-01 1996-01-29 Use of melatonin for treating patients suffering from drug addiction

Publications (3)

Publication Number Publication Date
JPH10513177A JPH10513177A (ja) 1998-12-15
JPH10513177A5 true JPH10513177A5 (enExample) 2010-05-06
JP4516159B2 JP4516159B2 (ja) 2010-08-04

Family

ID=26140195

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52338596A Expired - Lifetime JP4516159B2 (ja) 1995-02-01 1996-01-29 薬物嗜癖患者の治療のためのメラトニンの使用

Country Status (22)

Country Link
JP (1) JP4516159B2 (enExample)
CN (1) CN1083263C (enExample)
AT (1) AT408188B (enExample)
AU (1) AU695366B2 (enExample)
BG (1) BG62876B1 (enExample)
BR (1) BR9607169A (enExample)
CZ (1) CZ291349B6 (enExample)
DK (1) DK176081B1 (enExample)
EE (1) EE03384B1 (enExample)
FI (1) FI119586B (enExample)
IS (1) IS1980B (enExample)
LU (1) LU90118B1 (enExample)
LV (1) LV11940B (enExample)
MD (1) MD1716C2 (enExample)
NO (1) NO312814B1 (enExample)
NZ (1) NZ298878A (enExample)
PL (1) PL183148B1 (enExample)
SI (1) SI9620022A (enExample)
SK (1) SK284521B6 (enExample)
TR (1) TR199700723T1 (enExample)
TW (1) TW483757B (enExample)
WO (1) WO1996023496A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1272177T3 (da) 2000-01-05 2007-08-06 Neurim Pharma 1991 Fremgangsmåde og formulering til behandling af resistens over for antihypertensiva og forbundne tilstande
IL149377A (en) * 2002-04-28 2012-10-31 Neurim Pharma 1991 Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds
IL155666A (en) 2003-04-29 2013-12-31 Neurim Pharma 1991 Insomnia treatment
US9119846B2 (en) 2003-04-29 2015-09-01 Neurim Pharmaceuticals (1991) Ltd. Method and composition for enhancing cognition in alzheimer's patients
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
RU2631602C2 (ru) 2012-01-26 2017-09-25 Ванда Фармасьютиклз Инк. Лечение нарушений циркадного ритма
KR20170058464A (ko) 2012-12-18 2017-05-26 반다 파마슈티칼즈, 인코퍼레이티드. 일주기 리듬 장애의 치료
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
US10376487B2 (en) 2013-11-12 2019-08-13 Vanda Pharmaceuticals Inc. Method of treatment
EP3337462B1 (en) * 2016-10-31 2020-09-30 Neurim Pharmaceuticals Ltd. Melatonin mini-tablets and method of manufacturing the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0518468T3 (da) * 1991-05-09 2000-01-31 Neurim Pharma 1991 Melatoninholdige sammensætninger
IT1251544B (it) * 1991-05-13 1995-05-17 Gabriele Biella Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico

Similar Documents

Publication Publication Date Title
Roth et al. Consensus for the pharmacological management of insomnia in the new millennium
Waldinger et al. Ejaculation‐retarding properties of paroxetine in patients with primary premature ejaculation: a double‐blind, randomized, dose‐response study
EP1066038B1 (en) Use of cabergoline in the treatment of restless legs syndrome
Garfinkel et al. Improvement of sleep quality by controlled-release melatonin in benzodiazepine-treated elderly insomniacs
EP0724878B1 (en) Use of melatonin for treating patients suffering from drug dependencies
Wellington et al. Rizatriptan: an update of its use in the management of migraine
US20030008005A1 (en) Sublingual administration of dihydroergotamine for the treatment of migraine
JPH10513177A5 (enExample)
JP4516159B2 (ja) 薬物嗜癖患者の治療のためのメラトニンの使用
Monti Primary and secondary insomnia: prevalence, causes and current therapeutics
HK1052655A1 (zh) 用於治療對抗高血壓藥的抗藥性和相關病症的方法和製劑
Manfredi et al. Clinical neuropharmacology of sleep disorders
Jackson et al. Temazepam (Restoril, Sandoz Pharmaceuticals)
CA2211839C (en) Use of melatonin for treating patients suffering from drug addiction
Busto et al. Safety of ipsapirone treatment compared with lorazepam: discontinuation effects
Wurtman Ramelteon: a melatonin receptor agonist
HK1001218B (en) Use of melatonin for treating patients suffering from drug dependencies
MXPA97005856A (en) Use of melatonine in the manufacture of unmedicament to deal with addiction to dro
Lee-Chiong et al. Pharmacologic Therapy of Chronic Insomnia in Older Adults
SO et al. Sodium Oxybate in the Treatment of Narcolepsy
Potgieter Overview of clinical studies for acamprosate
Lahmeyer Pharmacology of sleep
Lee-Chiong et al. Pharmacologic therapy of insomnia